Changes to choline salicylate access to start from 1 October 2023
31 Aug 2023
From 1 October 2023, products containing choline salicylate for oromucosal (mouth) use will only be available for purchase at pharmacies.
Pharmacy medicines (Schedule 2 of the Poisons Standard) are those that may require advice from a pharmacist for safe use, and which should be available from a pharmacy or from a licensed person where a pharmacy service is not available.
In making this decision, the risks associated with prolonged use and overuse of choline salicylate, especially in children, were considered. The Therapeutic Guidelines in Australia do not recommend teething gels (irrespective of choline salicylate content) because of the lack of evidence of efficacy and the potential for harm.
The change was made in response to an application to amend the Poisons Standard, which was received in July 2021.
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
Popular Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy